日本新薬(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4516/E00931-
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2022/01/14日証協無担保37,796株+202.46%0株-100%205株-71.13%
2022/01/14日証協有担保78,568株+146.59%23,897株-21.39%8,013株-82.31%
2022/01/07日証協無担保12,496株-71.92%300株0%710株+9999.99%
2022/01/07日証協有担保31,862株-66.16%30,398株+98.07%45,300株-25.5%
2021/12/30日証協無担保44,500株0%0株0%6株0%
2021/12/30日証協有担保94,165株0%15,347株0%60,807株0%
2021/12/24日証協無担保44,500株+67.92%0株0%6株-98.08%
2021/12/24日証協有担保94,165株-34.53%15,347株-38.13%60,807株+50.14%
2021/12/17日証協無担保26,500株-58.58%0株0%312株-96.11%
2021/12/17日証協有担保143,824株+33.54%24,806株+5.41%40,500株-4.93%
2021/12/10日証協無担保63,975株0%0株0%8,012株+277.57%
2021/12/10日証協有担保107,705株-40.24%23,533株-79.21%42,600株+2.06%
2021/12/03日証協無担保0株-100%0株0%2,122株+9999.99%
2021/12/03日証協有担保180,226株+86.58%113,183株+360.77%41,740株+42.66%
2021/11/26日証協無担保1,116株0%0株0%6株-99.54%
2021/11/26日証協有担保96,595株+27.77%24,564株+3409.14%29,259株+32.9%
2021/11/19日証協無担保0株0%0株0%1,308株+159.01%
2021/11/19日証協有担保75,599株-15.23%700株-22.22%22,016株+27.26%
2021/11/05日証協無担保0株0%0株0%3株-99.89%
2021/11/05日証協有担保39,818株-88.57%3,700株+7.18%50,767株-74.68%
2021/10/29日証協無担保0株0%0株0%2,703株+2474.29%
2021/10/29日証協有担保348,390株-1.17%3,452株-62.48%200,498株+29.82%
2021/10/22日証協無担保0株0%0株0%105株-2.78%
2021/10/22日証協有担保352,513株+7.04%9,200株+10.15%154,448株+64.19%
2021/10/15日証協無担保0株-100%0株-100%108株-99.73%
2021/10/15日証協有担保329,315株-66.06%8,352株-55.6%94,067株-85.48%
2021/10/08日証協無担保13,415株+347.17%600株0%39,916株+352.67%
2021/10/08日証協有担保970,226株+390.8%18,811株-62.79%647,695株+335.13%
2021/10/01日証協無担保3,000株-80.77%0株0%8,818株+9999.99%
2021/10/01日証協有担保197,683株-19.35%50,554株+1230.37%148,852株+212.71%
2021/09/24日証協無担保15,600株+849.48%0株-100%2株-99.01%
2021/09/24日証協有担保245,114株-0.63%3,800株-97.27%47,600株-84.2%
2021/09/17日証協無担保1,643株-96.69%1,900株+533.33%203株-91.9%
2021/09/17日証協有担保246,680株+42.05%138,941株+1393.99%301,267株+525.26%
2021/09/10日証協無担保49,699株0%300株-93.17%2,506株+91.88%
2021/09/10日証協有担保173,652株+24.66%9,300株+232.14%48,183株-61.91%
2021/09/03日証協無担保0株-100%4,393株0%1,306株+44.31%
2021/09/03日証協有担保139,306株-3.41%2,800株-45.1%126,490株+1.65%

※株式分割は考慮していませんのでご注意ください。

Page Top